Stephanie L. Sherman

22.6k total citations · 1 hit paper
208 papers, 11.6k citations indexed

About

Stephanie L. Sherman is a scholar working on Genetics, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Stephanie L. Sherman has authored 208 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Genetics, 71 papers in Cognitive Neuroscience and 68 papers in Molecular Biology. Recurrent topics in Stephanie L. Sherman's work include Genetics and Neurodevelopmental Disorders (100 papers), Autism Spectrum Disorder Research (71 papers) and Genomic variations and chromosomal abnormalities (51 papers). Stephanie L. Sherman is often cited by papers focused on Genetics and Neurodevelopmental Disorders (100 papers), Autism Spectrum Disorder Research (71 papers) and Genomic variations and chromosomal abnormalities (51 papers). Stephanie L. Sherman collaborates with scholars based in United States, United Kingdom and Netherlands. Stephanie L. Sherman's co-authors include Emily G. Allen, Terry Hassold, Sallie B. Freeman, Dana C. Crawford, Juan Acuña, Eleanor Feingold, Lisa F. Taft, Ann Abramowitz, Lora Bean and Gillian Turner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Stephanie L. Sherman

206 papers receiving 11.2k citations

Hit Papers

Down syndrome 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie L. Sherman United States 55 6.8k 4.2k 3.6k 2.2k 2.1k 208 11.6k
Merlin G. Butler United States 60 10.4k 1.5× 5.8k 1.4× 1.9k 0.5× 3.0k 1.4× 509 0.2× 382 14.5k
Allison E. Ashley‐Koch United States 48 1.8k 0.3× 2.2k 0.5× 1.6k 0.4× 802 0.4× 517 0.2× 210 8.3k
Ignatia B. Van den Veyver United States 30 4.7k 0.7× 3.4k 0.8× 1.9k 0.5× 1.6k 0.7× 421 0.2× 105 6.7k
Bengt Hagberg Sweden 55 4.9k 0.7× 3.0k 0.7× 3.5k 1.0× 4.2k 1.9× 326 0.2× 236 12.1k
Dale R. Nyholt Australia 47 4.6k 0.7× 2.5k 0.6× 938 0.3× 498 0.2× 446 0.2× 178 10.9k
Joachim Hallmayer United States 56 3.7k 0.5× 3.9k 0.9× 4.0k 1.1× 604 0.3× 286 0.1× 174 11.7k
Rosanna Weksberg Canada 55 5.5k 0.8× 7.2k 1.7× 703 0.2× 3.1k 1.4× 482 0.2× 235 11.2k
Judith L. Ross United States 59 5.9k 0.9× 4.3k 1.0× 1.4k 0.4× 1.4k 0.6× 500 0.2× 212 10.0k
Eden R. Martin United States 57 4.1k 0.6× 4.4k 1.0× 1.5k 0.4× 250 0.1× 748 0.4× 241 11.2k
Stacey S. Cherny Hong Kong 45 5.3k 0.8× 3.3k 0.8× 677 0.2× 395 0.2× 347 0.2× 164 11.2k

Countries citing papers authored by Stephanie L. Sherman

Since Specialization
Citations

This map shows the geographic impact of Stephanie L. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie L. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie L. Sherman more than expected).

Fields of papers citing papers by Stephanie L. Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie L. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie L. Sherman. The network helps show where Stephanie L. Sherman may publish in the future.

Co-authorship network of co-authors of Stephanie L. Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie L. Sherman. A scholar is included among the top collaborators of Stephanie L. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie L. Sherman. Stephanie L. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ali, Nadia, et al.. (2022). The diagnostic experience of women with fragile X–associated primary ovarian insufficiency (FXPOI). Journal of Assisted Reproduction and Genetics. 40(1). 179–190. 8 indexed citations
2.
Albizua, Igor, Krista Charen, Lisa Shubeck, et al.. (2022). Descriptive analysis of seizures and comorbidities associated with fragile X syndrome. Molecular Genetics & Genomic Medicine. 10(8). e2001–e2001. 4 indexed citations
3.
Charen, Krista, Lisa Shubeck, Allyn McConkie‐Rosell, et al.. (2021). Men with an FMR1 premutation and their health education needs. Journal of Genetic Counseling. 30(4). 1156–1167. 1 indexed citations
4.
Abbeduto, Leonard, Elizabeth Berry‐Kravis, Audra Sterling, et al.. (2020). Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity. Journal of Neurodevelopmental Disorders. 12(1). 10–10. 39 indexed citations
5.
Nolin, Sarah L., Anne Glicksman, Emily G. Allen, et al.. (2019). Expansions and contractions of the FMR1 CGG repeat in 5,508 transmissions of normal, intermediate, and premutation alleles. American Journal of Medical Genetics Part A. 179(7). 1148–1156. 47 indexed citations
6.
Rambo‐Martin, Benjamin L., David J. Cutler, Lora Jh Bean, et al.. (2017). Analysis of Copy Number Variants on Chromosome 21 in Down Syndrome-Associated Congenital Heart Defects. G3 Genes Genomes Genetics. 8(1). 105–111. 11 indexed citations
7.
Kaufmann, Walter E., Sharon A. Kidd, Howard Andrews, et al.. (2017). Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment. PEDIATRICS. 139(Supplement_3). S194–S206. 186 indexed citations
8.
Mailick, Marsha R., Jinkuk Hong, Jan S. Greenberg, Leann E. Smith, & Stephanie L. Sherman. (2014). Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 165(8). 705–711. 49 indexed citations
9.
Li, Huiqing, Donna Klinedinst, Valerie B. DeLeon, et al.. (2012). Genetic Modifiers Predisposing to Congenital Heart Disease in the Sensitized Down Syndrome Population. Circulation Cardiovascular Genetics. 5(3). 301–308. 42 indexed citations
10.
Abrams, Liane, Amy Cronister, W. Ted Brown, et al.. (2012). Newborn, Carrier, and Early Childhood Screening Recommendations for Fragile X. PEDIATRICS. 130(6). 1126–1135. 29 indexed citations
11.
Allen, Emily G., Jessica Ezzell Hunter, Jorge L. Juncos, et al.. (2011). Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome.. Neuropsychology. 25(3). 404–411. 15 indexed citations
12.
Coffee, Bradford, et al.. (2009). Incidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA. The American Journal of Human Genetics. 85(4). 503–514. 304 indexed citations
13.
Allen, Emily G., Krista Charen, James R. Giles, et al.. (2008). Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Human Reproduction. 23(5). 1220–1225. 64 indexed citations
14.
Hunter, Jessica Ezzell, Michael P. Epstein, Stuart W. Tinker, Krista Charen, & Stephanie L. Sherman. (2008). Fragile X‐associated primary ovarian insufficiency: evidence for additional genetic contributions to severity. Genetic Epidemiology. 32(6). 553–559. 28 indexed citations
15.
Hunter, Jessica Ezzell, Emily G. Allen, Ann Abramowitz, et al.. (2008). No Evidence for a Difference in Neuropsychological Profile among Carriers and Noncarriers of the FMR1 Premutation in Adults under the Age of 50. The American Journal of Human Genetics. 83(6). 692–702. 61 indexed citations
16.
McConkie‐Rosell, Allyn, Liane Abrams, Brenda Finucane, et al.. (2007). Recommendations from Multi‐disciplinary Focus Groups on Cascade Testing and Genetic Counseling for Fragile X‐associated Disorders. Journal of Genetic Counseling. 16(5). 593–606. 48 indexed citations
17.
Wittenberger, Michael D., Randi J. Hagerman, Stephanie L. Sherman, et al.. (2006). The FMR1 premutation and reproduction. Fertility and Sterility. 87(3). 456–465. 297 indexed citations
18.
Sullivan, Amy K., Michele Marcus, Michael P. Epstein, et al.. (2004). Association of FMR1 repeat size with ovarian dysfunction. Human Reproduction. 20(2). 402–412. 345 indexed citations
19.
Crawford, Dana C., Kellen L. Meadows, James L. Newman, et al.. (2002). Prevalence of the fragile X syndrome in African‐Americans. American Journal of Medical Genetics. 110(3). 226–233. 113 indexed citations
20.
Crawford, Dana C., Juan Acuña, & Stephanie L. Sherman. (2001). FMR1 and the fragile X syndrome: Human genome epidemiology review. Genetics in Medicine. 3(5). 359–371. 477 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026